Maria Baggstrom - Publications

Health Insurance Type and Lung Cancer Stage Shift Following Coverage of Screening.

Journal: Health services research

Published: November 25, 2025

Racialized economic segregation and disparities in non-small cell lung cancer care and outcomes.

Journal: CHEST pulmonary

Published: September 25, 2025

Racialized Economic Segregation and Treatment and Outcomes of Small Cell Lung Cancer.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: February 13, 2024

Prevalence of Women in Medicine Programs at University-Based Internal Medicine Residency Programs.

Journal: Southern medical journal

Published: February 02, 2024

Investing in Women Trainees: Building a Women in Medicine Group at an Academic Institution.

Journal: Journal of medical Internet research

Published: April 01, 2023

Phase 1b trial of anti-VEGF/PDGFR vorolanib combined with immune checkpoint inhibitors in patients with advanced solid tumors.

Journal: Cancer chemotherapy and pharmacology

Published: October 22, 2021

Phase I Study of Accelerated Hypofractionated Proton Therapy and Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer.

Journal: International journal of radiation oncology, biology, physics

Published: September 13, 2021

Phase I Study of Docetaxel and Temsirolimus in Refractory Solid Tumors.

Journal: American journal of clinical oncology

Published: July 26, 2021

Phase 1 study combining alisertib with nab-paclitaxel in patients with advanced solid malignancies.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 19, 2021

A phase II study of everolimus in patients with advanced solid malignancies with TSC1, TSC2, NF1, NF2 or STK11 mutations.

Journal: Journal of thoracic disease

Published: January 29, 2021

Phase II Trial of Carfilzomib Plus Irinotecan in Patients With Small-cell Lung Cancer Who Have Progressed on Prior Platinum-based Chemotherapy.

Journal: Clinical lung cancer

Published: October 21, 2019

Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients With Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.

Journal: JAMA oncology

Published: August 09, 2019